Analysis | Metabolite Name | Measured Value | Units | AGE | Assay | DISEASE_STATE | Timepoint |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 171206 | Peak area normalized | 14 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 191385 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 198540 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 204389 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 211417 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 232435 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 237906 | Peak area normalized | 14 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 245675 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 249973 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 252379 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 253474 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 253917 | Peak area normalized | 14 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 257444 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 259260 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 261132 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 268011 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 271704 | Peak area normalized | 15 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 272847 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 273392 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 277568 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 283577 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 288286 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 292982 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 300024 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 305036 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 305183 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 309185 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 309856 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 310562 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 311158 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 311273 | Peak area normalized | 13 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 313035 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 314923 | Peak area normalized | 14 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 315668 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 315991 | Peak area normalized | 14 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 320287 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 324064 | Peak area normalized | 17 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 326585 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 327093 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 328336 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 331548 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 333466 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 334971 | Peak area normalized | 13 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 336386 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 339397 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 352150 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 353382 | Peak area normalized | 17 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 355986 | Peak area normalized | 15 | OGTT | PCOS | 90 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 372107 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 376612 | Peak area normalized | 13 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 379261 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 384209 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 387885 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 391707 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 396450 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 399980 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 401577 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 405497 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 408090 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 411801 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 420642 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 430618 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 431779 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 452244 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 457074 | Peak area normalized | 17 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 482725 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 488726 | Peak area normalized | 17 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 518450 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 525107 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 526908 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 536318 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 544613 | Peak area normalized | 15 | OGTT | PCOS | 30 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 546578 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 580981 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 596191 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 632539 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 688358 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 880140 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 982401 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 1169867 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area normalized | 12 | BC TP | PCOS | - | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area normalized | 13 | BC TP | PCOS | - | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area normalized | 14 | OGTT | Control | 120 | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area normalized | 15 | BC TP | Control | - | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area normalized | 15 | BC TP | PCOS | - | |
Reversed phase NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | Peak area normalized | 16 | BC TP | PCOS | - | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 86653 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 92194 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 105171 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 105563 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 107641 | Peak area normalized | 15 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 111297 | Peak area normalized | 15 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 112482 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 112583 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 115394 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 116547 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 116952 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 117032 | Peak area normalized | 14 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 117413 | Peak area normalized | 14 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 119364 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 119820 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 121446 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 121772 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 125186 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 125426 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 127271 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 128628 | Peak area normalized | 14 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 128866 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 129473 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 129662 | Peak area normalized | 12 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 131002 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 131735 | Peak area normalized | 13 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 133773 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 133789 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 133928 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 134679 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 135335 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 135900 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 135982 | Peak area normalized | 17 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 136149 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 136212 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 136392 | Peak area normalized | 15 | OGTT | PCOS | 90 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 136842 | Peak area normalized | 16 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 137284 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 137561 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 138743 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 139035 | Peak area normalized | 13 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 144742 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 144788 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 145525 | Peak area normalized | 14 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 146987 | Peak area normalized | 17 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 147722 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 147772 | Peak area normalized | 16 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 148489 | Peak area normalized | 13 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 148691 | Peak area normalized | 12 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 151704 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 154097 | Peak area normalized | 14 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 154298 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 155187 | Peak area normalized | 12 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 157987 | Peak area normalized | 12 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 158049 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 160788 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 161056 | Peak area normalized | 13 | OGTT | Control | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 163764 | Peak area normalized | 14 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 167540 | Peak area normalized | 12 | BC TP | Control | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 168807 | Peak area normalized | 13 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 170185 | Peak area normalized | 15 | BC TP | PCOS | 270 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 172285 | Peak area normalized | 13 | BC TP | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 173286 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 177088 | Peak area normalized | 17 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 177490 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 178550 | Peak area normalized | 15 | BC TP | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 185003 | Peak area normalized | 13 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 186922 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 188374 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 190260 | Peak area normalized | 12 | OGTT | Control | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 209595 | Peak area normalized | 15 | OGTT | PCOS | 30 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 211357 | Peak area normalized | 13 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 217024 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 220893 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 221698 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 227170 | Peak area normalized | 17 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 234180 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 235964 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 245654 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 257007 | Peak area normalized | 12 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 268135 | Peak area normalized | 15 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 268865 | Peak area normalized | 16 | OGTT | PCOS | 120 |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 283366 | Peak area normalized | 16 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 302737 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 328212 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 333614 | Peak area normalized | 15 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 337051 | Peak area normalized | 12 | OGTT | PCOS | - |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | Peak area normalized | 12 | BC TP | Control | 270 | |
Reversed phase POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | Peak area normalized | 15 | BC TP | PCOS | 270 |